Analyzing biotech clinical trial risk: Frank David, founder of Pharmagellan
33:22
Case study in analyzing biotech clinical trial risk
19:46
Analyzing the clinical data for Aduhelm, Biogen's controversial Alzheimer's drug
10:04
How to create opportunities out of nothing | Marcel Lienhard | TEDxHWZ
1:01:29
Biotech Forecasting and Valuation with Frank David, MD, PhD
57:41
STAT Virtual Event: Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D
22:03
What Are the Best Funding Strategies for Biotech Startups?
24:01
How dilution can crush biotech returns
1:29:48